Lutetium-177 Market Size, Share & Industry Analysis, By Drug (LUTATHERA {lutetium Lu 177 dotatate}, PLUVICTO {lutetium Lu 177 vipivotide tetraxetan}, and Others) By Age Group (Adults and Pediatrics), By Application (Neuroendocrine Tumor, Prostate Cancer, and Others) By End-User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI112740

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases, By Key Countries/Regions, 2024
2. Pipeline Analysis, by Key Players
3. New Product Launches, by Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Impact of COVID-19 on the Market
Global Lutetium-177 Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. LUTATHERA (lutetium Lu 177 dotatate)
  2. PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)
  3. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Adults
  2. Pediatrics
3. Market Analysis, Insights and Forecast – By Application
  1. Neuroendocrine Tumors
  2. Prostate Cancer
  3. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Lutetium-177 Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. LUTATHERA (lutetium Lu 177 dotatate)
  2. PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)
  3. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Adults
  2. Pediatrics
3. Market Analysis, Insights and Forecast – By Application
  1. Neuroendocrine Tumors
  2. Prostate Cancer
  3. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Lutetium-177 Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. LUTATHERA (lutetium Lu 177 dotatate)
  2. PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)
  3. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Adults
  2. Pediatrics
3. Market Analysis, Insights and Forecast – By Application
  1. Neuroendocrine Tumors
  2. Prostate Cancer
  3. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Lutetium-177 Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. LUTATHERA (lutetium Lu 177 dotatate)
  2. PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)
  3. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Adults
  2. Pediatrics
3. Market Analysis, Insights and Forecast – By Application
  1. Neuroendocrine Tumors
  2. Prostate Cancer
  3. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Rest of the World Lutetium-177 Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. LUTATHERA (lutetium Lu 177 dotatate)
  2. PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)
  3. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Adults
  2. Pediatrics
3. Market Analysis, Insights and Forecast – By Application
  1. Neuroendocrine Tumors
  2. Prostate Cancer
  3. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals
  2. Specialty Clinics
  3. Others
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. Novartis AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Telix Pharmaceuticals Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Ariceum Therapeutics
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Radiopharm Theranostics Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Lantheus Holdings, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Y-mAbs Therapeutics, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. GLYTHERIX
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Curium
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases, By Key Countries/Regions, 2024
2. Pipeline Analysis, by Key Players
3. New Product Launches, by Key Players
4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Impact of COVID-19 on the Market
Global Lutetium-177 Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. LUTATHERA (lutetium Lu 177 dotatate)
  2. PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)
  3. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Adults
  2. Pediatrics
3. Market Analysis, Insights and Forecast – By Application
  1. Neuroendocrine Tumors
  2. Prostate Cancer
  3. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Lutetium-177 Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. LUTATHERA (lutetium Lu 177 dotatate)
  2. PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)
  3. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Adults
  2. Pediatrics
3. Market Analysis, Insights and Forecast – By Application
  1. Neuroendocrine Tumors
  2. Prostate Cancer
  3. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Lutetium-177 Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. LUTATHERA (lutetium Lu 177 dotatate)
  2. PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)
  3. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Adults
  2. Pediatrics
3. Market Analysis, Insights and Forecast – By Application
  1. Neuroendocrine Tumors
  2. Prostate Cancer
  3. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Lutetium-177 Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. LUTATHERA (lutetium Lu 177 dotatate)
  2. PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)
  3. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Adults
  2. Pediatrics
3. Market Analysis, Insights and Forecast – By Application
  1. Neuroendocrine Tumors
  2. Prostate Cancer
  3. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals
  2. Specialty Clinics
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Rest of the World Lutetium-177 Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Drug
  1. LUTATHERA (lutetium Lu 177 dotatate)
  2. PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)
  3. Others
2. Market Analysis, Insights and Forecast – By Age Group
  1. Adults
  2. Pediatrics
3. Market Analysis, Insights and Forecast – By Application
  1. Neuroendocrine Tumors
  2. Prostate Cancer
  3. Others
4. Market Analysis, Insights and Forecast – By End-User
  1. Hospitals
  2. Specialty Clinics
  3. Others
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. Novartis AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Telix Pharmaceuticals Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Ariceum Therapeutics
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Radiopharm Theranostics Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Lantheus Holdings, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Y-mAbs Therapeutics, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. GLYTHERIX
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Curium
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Lutetium-177 Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Lutetium-177 Market Value Share (%), by Drug, 2024 & 2032

Figure 3: Global Lutetium-177 Market Value Share (%), by Age Group, 2024 & 2032

Figure 4: Global Lutetium-177 Market Value Share (%), by Application, 2024 & 2032

Figure 5: Global Lutetium-177 Market Value Share (%), by End-User, 2024 & 2032

Figure 6: North America Lutetium-177 Market Value (USD billion), by Drug, 2024 & 2032

Figure 7: North America Lutetium-177 Market Value Share (%), by Drug, 2024

Figure 8: North America Lutetium-177 Market Value (USD billion), by Age Group, 2024 & 2032

Figure 9: North America Lutetium-177 Market Value Share (%), by Age Group, 2024

Figure 10: North America Lutetium-177 Market Value (USD billion), by Application, 2024 & 2032

Figure 11: North America Lutetium-177 Market Value Share (%), by Application, 2024

Figure 12: North America Lutetium-177 Market Value (USD billion), by End-User, 2024 & 2032

Figure 13: North America Lutetium-177 Market Value Share (%), by End-User, 2024

Figure 14: North America Lutetium-177 Market Value (USD billion), By Country, 2024 & 2032

Figure 15: North America Lutetium-177 Market Value Share (%), By Country, 2024

Figure 16: Europe Lutetium-177 Market Value (USD billion), by Drug, 2024 & 2032

Figure 17: Europe Lutetium-177 Market Value Share (%), by Drug, 2024

Figure 18: Europe Lutetium-177 Market Value (USD billion), by Age Group, 2024 & 2032

Figure 19: Europe Lutetium-177 Market Value Share (%), by Age Group, 2024

Figure 20: Europe Lutetium-177 Market Value (USD billion), by Application, 2024 & 2032

Figure 21: Europe Lutetium-177 Market Value Share (%), by Application, 2024

Figure 22: Europe Lutetium-177 Market Value (USD billion), by End-User, 2024 & 2032

Figure 23: Europe Lutetium-177 Market Value Share (%), by End-User, 2024

Figure 24: Europe Lutetium-177 Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 25: Europe Lutetium-177 Market Value Share (%), By Country/ Sub-region, 2024

Figure 26: Asia Pacific Lutetium-177 Market Value (USD billion), by Drug, 2024 & 2032

Figure 27: Asia Pacific Lutetium-177 Market Value Share (%), by Drug, 2024

Figure 28: Asia Pacific Lutetium-177 Market Value (USD billion), by Age Group, 2024 & 2032

Figure 29: Asia Pacific Lutetium-177 Market Value Share (%), by Age Group, 2024

Figure 30: Asia Pacific Lutetium-177 Market Value (USD billion), by Application, 2024 & 2032

Figure 31: Asia Pacific Lutetium-177 Market Value Share (%), by Application, 2024

Figure 32: Asia Pacific Lutetium-177 Market Value (USD billion), by End-User, 2024 & 2032

Figure 33: Asia Pacific Lutetium-177 Market Value Share (%), by End-User, 2024

Figure 34: Asia Pacific Lutetium-177 Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 35: Asia Pacific Lutetium-177 Market Value Share (%), By Country/ Sub-region, 2024

Figure 36: Rest of the World Lutetium-177 Market Value (USD billion), by Drug, 2024 & 2032

Figure 37: Rest of the World Lutetium-177 Market Value Share (%), by Drug, 2024

Figure 38: Rest of the World Lutetium-177 Market Value (USD billion), by Age Group, 2024 & 2032

Figure 39: Rest of the World Lutetium-177 Market Value Share (%), by Age Group, 2024

Figure 40: Rest of the World Lutetium-177 Market Value (USD billion), by Application, 2024 & 2032

Figure 41: Rest of the World Lutetium-177 Market Value Share (%), by Application, 2024

Figure 42: Rest of the World Lutetium-177 Market Value (USD billion), by End-User, 2024 & 2032

Figure 43: Rest of the World Lutetium-177 Market Value Share (%), by End-User, 2024

Figure 44: Rest of the World Lutetium-177 Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 45: Rest of the World Lutetium-177 Market Value Share (%), By Country/ Sub-region, 2024

Figure 46: Global Lutetium-177 Market Share (%), By Company, 2024

List of Tables

Table 1: Global Lutetium-177 Market Revenue (USD billion) Forecast, by Drug, 2019–2032

Table 2: Global Lutetium-177 Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 3: Global Lutetium-177 Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 4: Global Lutetium-177 Market Revenue (USD billion) Forecast, by End-User, 2019–2032

Table 5: Global Lutetium-177 Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 6: North America Lutetium-177 Market Revenue (USD billion) Forecast, by Drug, 2019-2032

Table 7: North America Lutetium-177 Market Revenue (USD billion) Forecast, by Age Group, 2019-2032

Table 8: North America Lutetium-177 Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 9: North America Lutetium-177 Market Revenue (USD billion) Forecast, by End-User, 2019-2032

Table 10: North America Lutetium-177 Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 11: Europe Lutetium-177 Market Revenue (USD billion) Forecast, by Drug, 2019-2032

Table 12: Europe Lutetium-177 Market Revenue (USD billion) Forecast, by Age Group, 2019-2032

Table 13: Europe Lutetium-177 Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 14: Europe Lutetium-177 Market Revenue (USD billion) Forecast, by End-User, 2019-2032

Table 15: Europe Lutetium-177 Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Asia Pacific Lutetium-177 Market Revenue (USD billion) Forecast, by Drug, 2019-2032

Table 17: Asia Pacific Lutetium-177 Market Revenue (USD billion) Forecast, by Age Group, 2019-2032

Table 18: Asia Pacific Lutetium-177 Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 19: Asia Pacific Lutetium-177 Market Revenue (USD billion) Forecast, by End-User, 2019-2032

Table 20: Asia Pacific Lutetium-177 Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 21: Rest of the World Lutetium-177 Market Revenue (USD billion) Forecast, by Drug, 2019-2032

Table 22: Rest of the World Lutetium-177 Market Revenue (USD billion) Forecast, by Age Group, 2019-2032

Table 23: Rest of the World Lutetium-177 Market Revenue (USD billion) Forecast, by Application, 2019-2032

Table 24: Rest of the World Lutetium-177 Market Revenue (USD billion) Forecast, by End-User, 2019-2032

Table 25: Rest of the World Lutetium-177 Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 150

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Radiotheranostics Market

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com